Get started
IONIS PHARMACEUTICALS INCIONIS PHARMACEUTICALS INCIONIS PHARMACEUTICALS INC

IONIS PHARMACEUTICALS INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Bonds

1IONS chart


Full chart

1IONS upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪4.68 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.76 EUR
Net income (FY)
‪−438.45 M‬ EUR
Revenue (FY)
‪681.15 M‬ EUR
Shares float
‪155.27 M‬
Beta (1Y)
0.79

Employees


Employees (FY)
‪1.07 K‬
Change (1Y)
+142 +15.32%
Revenue / Employee (1Y)
‪637.18 K‬ EUR
Net income / Employee (1Y)
‪−410.15 K‬ EUR

About Ionis Pharmaceuticals, Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Brett P. Monia
Website
ionis.com
Headquarters
Carlsbad
Founded
1989
FIGI
BBG01TNY3J55
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

1IONS news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

1IONS highest yielding bonds


IONS5835891
Ionis Pharmaceuticals, Inc. 1.75% 15-JUN-2028
Yield to maturity
1.66%
Maturity date
Jun 15, 2028
IONS5397611
Ionis Pharmaceuticals, Inc. 0.0% 01-APR-2026
Yield to maturity
1.22%
Maturity date
Apr 1, 2026

See all 1IONS bonds 


Check out other big names from the same industry as 1IONS.

Frequently Asked Questions


The current price of 1IONS is 29.55 EUR — it has increased by 1.80% in the past 24 hours. Watch IONIS PHARMACEUTICALS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange IONIS PHARMACEUTICALS INC stocks are traded under the ticker 1IONS.
1IONS stock has fallen by −3.28% compared to the previous week, the month change is a 13.93% rise, over the last year IONIS PHARMACEUTICALS INC has showed a 14.31% increase.
We've gathered analysts' opinions on IONIS PHARMACEUTICALS INC future price: according to them, 1IONS price has a max estimate of 74.20 EUR and a min estimate of 33.08 EUR. Watch 1IONS chart and read a more detailed IONIS PHARMACEUTICALS INC stock forecast: see what analysts think of IONIS PHARMACEUTICALS INC and suggest that you do with its stocks.
1IONS reached its all-time high on May 20, 2025 with the price of 30.45 EUR, and its all-time low was 25.85 EUR and was reached on Apr 25, 2025. View more price dynamics on 1IONS chart.
See other stocks reaching their highest and lowest prices.
1IONS stock is 0.34% volatile and has beta coefficient of 0.79. Track IONIS PHARMACEUTICALS INC stock price on the chart and check out the list of the most volatile stocks — is IONIS PHARMACEUTICALS INC there?
Today IONIS PHARMACEUTICALS INC has the market capitalization of ‪4.57 B‬, it has decreased by −0.56% over the last week.
Yes, you can track IONIS PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
IONIS PHARMACEUTICALS INC is going to release the next earnings report on Jul 31, 2025. Keep track of upcoming events with our Earnings Calendar.
1IONS earnings for the last quarter are −0.86 EUR per share, whereas the estimation was −1.01 EUR resulting in a 15.28% surprise. The estimated earnings for the next quarter are −0.37 EUR per share. See more details about IONIS PHARMACEUTICALS INC earnings.
IONIS PHARMACEUTICALS INC revenue for the last quarter amounts to ‪122.01 M‬ EUR, despite the estimated figure of ‪121.45 M‬ EUR. In the next quarter, revenue is expected to reach ‪220.06 M‬ EUR.
1IONS net income for the last quarter is ‪−135.82 M‬ EUR, while the quarter before that showed ‪−100.46 M‬ EUR of net income which accounts for −35.20% change. Track more IONIS PHARMACEUTICALS INC financial stats to get the full picture.
No, 1IONS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 29, 2025, the company has ‪1.07 K‬ employees. See our rating of the largest employees — is IONIS PHARMACEUTICALS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IONIS PHARMACEUTICALS INC EBITDA is ‪−415.83 M‬ EUR, and current EBITDA margin is −64.26%. See more stats in IONIS PHARMACEUTICALS INC financial statements.
Like other stocks, 1IONS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IONIS PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.